{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T07:42:34Z","timestamp":1793173354213,"version":"4.5.0"},"reference-count":96,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,20]],"date-time":"2022-08-20T00:00:00Z","timestamp":1660953600000},"content-version":"vor","delay-in-days":384,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.jacc.2021.06.022","type":"journal-article","created":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T16:58:49Z","timestamp":1628528329000},"page":"737-751","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":139,"title":["Increasing Participation of Women in Cardiovascular Trials"],"prefix":"10.1016","volume":"78","author":[{"given":"Leslie","family":"Cho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda R.","family":"Vest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle L.","family":"O\u2019Donoghue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Modele O.","family":"Ogunniyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy A.","family":"Sarma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara J.","family":"Denby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily S.","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne E.","family":"Poole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn J.","family":"Lindley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxana","family":"Mehran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2021.06.022_bib1","series-title":"National Institutes of Health Revitalization Act of 1993 Public Law 103-43 Clinical Research Equity Regarding Women and Minorities","year":"1993"},{"issue":"18","key":"10.1016\/j.jacc.2021.06.022_bib2","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1016\/j.jacc.2018.02.070","article-title":"Participation of women in clinical trials supporting FDA approval of cardiovascular drugs","volume":"71","author":"Scott","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.jacc.2021.06.022_bib3","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1089\/jwh.2007.0688","article-title":"Women\u2019s health and women\u2019s leadership in academic medicine: hitting the same glass ceiling?","volume":"17","author":"Carnes","year":"2008","journal-title":"J\u00a0Womens Health"},{"key":"10.1016\/j.jacc.2021.06.022_bib4","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1093\/eurheartj\/ehv161","article-title":"Gender differences in the effect of cardiovascular drugs: a position document of the Working Group on Pharmacology and Drug Therapy of the ESC","volume":"36","author":"Rosano","year":"2015","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.jacc.2021.06.022_bib5","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nrd2032","article-title":"Therapeutic implications of the gender-specific aspects of cardiovascular disease","volume":"5","author":"Regitz-Zagrosek","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jacc.2021.06.022_bib6","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/S0140-6736(19)31792-1","article-title":"Identifying optimal doses of heart failure medications in men compared with women: a prospective, observational, cohort study","volume":"394","author":"Santema","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2021.06.022_bib7","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1161\/CIR.0000000000000757","article-title":"Heart disease and stroke statistics-2020 update: a report from the American Heart Association","volume":"141","author":"Virani","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2021.06.022_bib8","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1161\/CIRCULATIONAHA.119.041728","article-title":"Overcoming lack of diversity in cardiovascular clinical trials: a new challenge and strategies for success","volume":"140","author":"Ortega","year":"2019","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.jacc.2021.06.022_bib9","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.cpcardiol.2018.11.002","article-title":"Increasing diversity in clinical trials: overcoming critical barriers","volume":"44","author":"Clark","year":"2019","journal-title":"Curr Prob Cardiol"},{"issue":"11","key":"10.1016\/j.jacc.2021.06.022_bib10","article-title":"Ten-year trends in enrollment of women and minorities in pivotal trials supporting recent US Food and Drug Administration approval of novel cardiometabolic drugs","volume":"9","author":"Khan","year":"2020","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2021.06.022_bib11","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1001\/jamacardio.2018.2559","article-title":"Enrollment of older patients, women, and racial and ethnic minorities in contemporary heart failure clinical trials: a systematic review","volume":"3","author":"Tahhan","year":"2018","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2021.06.022_bib12","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1001\/jamacardio.2020.0359","article-title":"Enrollment of older patients, women, and racial\/ethnic minority groups in contemporary acute coronary syndrome clinical trials: a systematic review","volume":"5","author":"Tahhan","year":"2020","journal-title":"JAMA Cardiol"},{"issue":"7","key":"10.1016\/j.jacc.2021.06.022_bib13","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1161\/CIRCULATIONAHA.119.043594","article-title":"Women's participation in cardiovascular clinical trials from 2010 to 2017","volume":"141","author":"Jin","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2021.06.022_bib14","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1056\/NEJM199711273372202","article-title":"A\u00a0comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias","volume":"337","year":"1997","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.jacc.2021.06.022_bib15","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa013474","article-title":"Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction","volume":"346","author":"Moss","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2021.06.022_bib16","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter\u2013defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2021.06.022_bib17","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1056\/NEJMoa032423","article-title":"Comparison of Medical Therapy, Pacing, and Defibrillation in Heart\u00a0Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure","volume":"350","author":"Bristow","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2021.06.022_bib18","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMoa1707855","article-title":"Catheter ablation for atrial fibrillation with heart failure","volume":"379","author":"Marrouche","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2021.06.022_bib19","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/jama.2019.0693","article-title":"Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: the CABANA randomized clinical trial","volume":"321","author":"Packer","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2021.06.022_bib20","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1056\/NEJMoa2019422","article-title":"Early rhythm-control therapy in patients with atrial fibrillation","volume":"383","author":"Kirchhof","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2021.06.022_bib21","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1161\/CIRCULATIONAHA.108.825133","article-title":"Differences in specialist consultations for cardiovascular disease by race, ethnicity, gender, insurance status, and site of primary care","volume":"119","author":"Cook","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2021.06.022_bib22","first-page":"690","article-title":"Consultation with cardiologists for persons with new-onset chronic heart failure: a population-based study","volume":"25","author":"Ehrmann Feldman","year":"2009","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jacc.2021.06.022_bib23","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.119.006082","article-title":"Sex-based differences in left ventricular assist device utilization: insights from the Nationwide Inpatient Sample 2004 to 2016","volume":"12","author":"Joshi","year":"2019","journal-title":"Circ Heart Fail"},{"issue":"2","key":"10.1016\/j.jacc.2021.06.022_bib24","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/ehjqcco\/qcz040","article-title":"Healthcare disparities for women hospitalized with myocardial infarction and angina","volume":"6","author":"Jackson","year":"2020","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"10.1016\/j.jacc.2021.06.022_bib25","first-page":"703","article-title":"Gender differences in clinical outcomes after catheter ablation of atrial fibrillation","volume":"2","author":"Kaiser","year":"2016","journal-title":"J\u00a0Am Coll Cardiol EP"},{"key":"10.1016\/j.jacc.2021.06.022_bib26","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1161\/CIRCULATIONAHA.115.021048","article-title":"Sex and race\/ethnicity differences in implantable cardioverter-defibrillator counseling and use among patients hospitalized with heart failure: findings from the get with the guidelines-heart failure program","volume":"134","author":"Hess","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2021.06.022_bib27","first-page":"85","article-title":"Population-level sex differences and predictors for treatment with catheter ablation in patients with atrial fibrillation and heart failure","volume":"3","author":"Samuels","year":"2020","journal-title":"Can J Cardiol Open"},{"key":"10.1016\/j.jacc.2021.06.022_bib28","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1471-2288-9-40","article-title":"Identifying strategies to maximise recruitment and retention of practices and patients in a multicentre randomised controlled trial of an intervention to optimise secondary prevention for coronary heart disease in primary care","volume":"9","author":"Leathem","year":"2009","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.jacc.2021.06.022_bib29","doi-asserted-by":"crossref","first-page":"113009","DOI":"10.1016\/j.socscimed.2020.113009","article-title":"Racial\/ethnic concordance between patients and researchers as a predictor of study attrition","volume":"255","author":"Mindlis","year":"2020","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.jacc.2021.06.022_bib30","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.24583","article-title":"Association of racial\/ethnic and gender concordance between patients and physicians with patient experience ratings","volume":"3","author":"Takeshita","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jacc.2021.06.022_bib31","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1186\/s13063-020-04358-3","article-title":"Digital tools for the recruitment and retention of participants in randomised controlled trials: a systematic map","volume":"21","author":"Frampton","year":"2020","journal-title":"Trials"},{"key":"10.1016\/j.jacc.2021.06.022_bib32","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1745-6215-15-23","article-title":"Recruitment and retention of young women into nutrition research studies: practical considerations","volume":"15","author":"Leonard","year":"2014","journal-title":"Trials"},{"key":"10.1016\/j.jacc.2021.06.022_bib33","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/cts.12285","article-title":"Culturally competent strategies for recruitment and retention of African American populations into clinical trials","volume":"8","author":"Otado","year":"2015","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.jacc.2021.06.022_bib34","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/NNR.0000000000000356","article-title":"Approaches to recruitment of postmenopausal women for a community-based study","volume":"68","author":"Waltman","year":"2019","journal-title":"Nurs Res"},{"key":"10.1016\/j.jacc.2021.06.022_bib35","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.2196\/resprot.8842","article-title":"mHealth intervention promoting cardiovascular health among African-Americans: recruitment and baseline characteristics of a pilot study","volume":"7","author":"Brewer","year":"2018","journal-title":"JMIR Res Protoc"},{"issue":"381","key":"10.1016\/j.jacc.2021.06.022_bib36","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1056\/NEJMoa1901183","article-title":"Large scale assessment of a smart watch to identify atrial fibrillation","volume":"14","author":"Perez","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2021.06.022_bib37","doi-asserted-by":"crossref","first-page":"e278","DOI":"10.1200\/OP.20.00630","article-title":"Development of an actionable framework to address cancer care disparities in medically underserved populations in the United States: expert roundtable recommendations","volume":"17","author":"Winkfield","year":"2021","journal-title":"JCO Oncol Pract"},{"key":"10.1016\/j.jacc.2021.06.022_bib38","author":"Stein"},{"key":"10.1016\/j.jacc.2021.06.022_bib39","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1001\/jamainternmed.2020.2750","article-title":"Representation of older adults in cardiovascular disease trial since the inclusion across the lifespan policy","volume":"180","author":"Nanna","year":"2020","journal-title":"JAMA Int Med"},{"key":"10.1016\/j.jacc.2021.06.022_bib41","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41746-020-0277-8","article-title":"Translating evidence into practice:eligibility criteria fail to eliminate clinically significant difference between real work and study population","volume":"3","author":"Averitt","year":"2020","journal-title":"NPJ Digit Med"},{"key":"10.1016\/j.jacc.2021.06.022_bib42","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1076-7460.2004.01709.x","article-title":"Willingness to participate in cardiac trials","volume":"13","author":"Peterson","year":"2004","journal-title":"Am J Geriatr Cardiol"},{"key":"10.1016\/j.jacc.2021.06.022_bib43","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1001\/archinte.167.9.905","article-title":"Sex differences in perceived risks, distrust, and willingness to participate in clinical trials: a randomized study of cardiovascular prevention trials","volume":"167","author":"Ding","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2021.06.022_bib44","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1089\/jwh.2012.3733","article-title":"Dialogues on diversifying clinical trials: successful strategies for engaging women and minorities in clinical trials","volume":"21","author":"Coakley","year":"2012","journal-title":"J\u00a0Womens Health"},{"key":"10.1016\/j.jacc.2021.06.022_bib45","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1177\/1740774506070812","article-title":"Reasons for participation and non-participation in a randomized controlled trial: postal questionnaire surveys of women eligible for TOMBOLA (Trial Of Management of Borderline and Other Low-Grade Abnormal smears)","volume":"3","author":"Sharp","year":"2006","journal-title":"Clin Trials"},{"key":"10.1016\/j.jacc.2021.06.022_bib46","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1016\/j.jacc.2020.09.544","article-title":"Conduct of clinical trials in the era of COVID-19: JACC Scientific Expert Panel","volume":"76","author":"Psotka","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2021.06.022_bib47","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/inthealth\/ihaa066","article-title":"Towards a fair and transparent research participant compensation and reimbursement framework in Vietnam","volume":"12","author":"Sansom","year":"2020","journal-title":"Int Health"},{"key":"10.1016\/j.jacc.2021.06.022_bib48","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2020-000391","article-title":"Overcoming barriers to recruitment and retention of African-American women with SLE in behavioural interventions: lessons learnt from the WELL study","volume":"7","author":"Drenkard","year":"2020","journal-title":"Lupus Sci Med"},{"issue":"7","key":"10.1016\/j.jacc.2021.06.022_bib49","doi-asserted-by":"crossref","first-page":"e239","DOI":"10.1161\/CIR.0000000000000907","article-title":"Ten-year differences in women's awareness related to coronary heart disease: results of the 2019 American Heart Association National Survey: a special report from the American Heart Association","volume":"143","author":"Cushman","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2021.06.022_bib50","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12874-019-0679-y","article-title":"Strategies for recruitment and retention of underrepresented populations with chronic obstructive pulmonary disease for a clinical trial","volume":"19","author":"Huang","year":"2019","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.jacc.2021.06.022_bib51","series-title":"Achieving diversity, inclusion, and equity in clinical research Version 1.1","author":"Bierer","year":"2021"},{"key":"10.1016\/j.jacc.2021.06.022_bib52","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.jacc.2020.12.031","article-title":"American College of Cardiology Cardiovascular Disease in Women Section. Does patient-physician gender concordance influence patient perceptions or outcomes?","volume":"77","author":"Lau","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2021.06.022_bib53","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/clc.22907","article-title":"Taking cardiology clinical trials to the next level: a call to action","volume":"41","author":"Clayton","year":"2018","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jacc.2021.06.022_bib54","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1056\/NEJMsa053910","article-title":"The \u201cgender gap\u201d in authorship of acadmic medical literature - a 35-year perspective","volume":"355","author":"Jagsi","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2021.06.022_bib55","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.118.005040","article-title":"Sex disparities in authorship order of cardiology scientific publications: trends over 40 years","volume":"11","author":"Ouyang","year":"2018","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2021.06.022_bib56","first-page":"471","article-title":"Female authorship in preclinical cardiovascular research","volume":"4","author":"Labinaz","year":"2019","journal-title":"J\u00a0Am Coll Cardiol Basic Transl Sci"},{"key":"10.1016\/j.jacc.2021.06.022_bib57","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1001\/jamainternmed.2020.2485","article-title":"Representation of women in cardiovascular clinical trial leadership","volume":"180","author":"Denby","year":"2020","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jacc.2021.06.022_bib58","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1016\/j.jacc.2020.08.062","article-title":"Characteristics of heart failure trials associated with under-representation of women as lead authors","volume":"76","author":"Whitelaw","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2021.06.022_bib59","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1001\/jamainternmed.2020.2489","article-title":"Time to end \u201cmanels\u201d in clinical trial leadership","volume":"180","author":"Wang","year":"2020","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jacc.2021.06.022_bib60","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1161\/CIRCHEARTFAILURE.119.006605","article-title":"Representation of women authors in international heart failure guidelines and contemporary clinical trials","volume":"13","author":"Reza","year":"2020","journal-title":"Circ Heart Fail"},{"issue":"10","key":"10.1016\/j.jacc.2021.06.022_bib61","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0079147","article-title":"Gender-heterogeneous working groups produce higher quality science","volume":"8","author":"Campbell","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jacc.2021.06.022_bib62","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1126\/science.1193147","article-title":"Evidence for collective intelligence factor in the performance of human groups","volume":"330","author":"Woolley","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.jacc.2021.06.022_bib63","article-title":"Research: when gender diversity makes firms more productive","author":"Turban","year":"2019","journal-title":"Harvard Business Review"},{"key":"10.1016\/j.jacc.2021.06.022_bib64","article-title":"Why diverse teams are smarter","author":"Rock","year":"2016","journal-title":"Harvard Business Review"},{"key":"10.1016\/j.jacc.2021.06.022_bib65","article-title":"The most creative teams have a specific type of cultural diversity","author":"Jang","year":"2018","journal-title":"Harvard Business Review"},{"key":"10.1016\/j.jacc.2021.06.022_bib66","article-title":"How diversity can drive innovation","author":"Hewlett","year":"2013","journal-title":"Harvard Business Review"},{"key":"10.1016\/j.jacc.2021.06.022_bib67","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1016\/j.jacc.2006.06.020","article-title":"Outcomes by gender in the African-American Heart\u00a0Failure Trial","volume":"48","author":"Taylor","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2021.06.022_bib68","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1056\/NEJMoa1717250","article-title":"A\u00a0cluster-randomized trial of blood-pressure reduction in black barbershops","volume":"378","author":"Victor","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2021.06.022_bib69","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.118.004691","article-title":"Cluster randomized clinical trial of FAITH (Faith-Based Approaches in the Treatment of Hypertension) in blacks","volume":"11","author":"Schoenthaler","year":"2018","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2021.06.022_bib70","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s11886-020-01319-9","article-title":"Barbershop management of hypertension in the African American population: pitfalls and opportunities for extension to other underserved communities","volume":"22","author":"Ebinger","year":"2020","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.jacc.2021.06.022_bib71","doi-asserted-by":"crossref","first-page":"708","DOI":"10.18549\/PharmPract.2016.01.708","article-title":"Women's involvement in clinical trials: historical perspective and future implications","volume":"14","author":"Liu","year":"2016","journal-title":"Pharm Pract (Granada)"},{"key":"10.1016\/j.jacc.2021.06.022_bib72","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0140-6736(10)60257-7","article-title":"Enrolling pregnant women in biomedical research","volume":"375","author":"Macklin","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2021.06.022_bib73","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1097\/AOG.0000000000001150","article-title":"646: ethical considerations for including women as research participants","volume":"126","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jacc.2021.06.022_bib74","doi-asserted-by":"crossref","first-page":"e320","DOI":"10.1097\/AOG.0000000000003243","article-title":"ACOG practice bulletin no. 212: pregnancy and heart disease","volume":"133","year":"2019","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jacc.2021.06.022_bib75","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1016\/j.jacc.2020.09.601","article-title":"Pre-pregnancy hypertension among women in rural and urban areas of the United States","volume":"76","author":"Cameron","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2021.06.022_bib76","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A\u00a0randomized trial of intensive versus standard blood-pressure control","volume":"373","author":"Wright","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2021.06.022_bib77","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1161\/HYPERTENSIONAHA.118.11660","article-title":"Estimated impact of the 2017 American College of Cardiology\/American Heart Association blood pressure guidelines on reproductive-aged women","volume":"72","author":"Topel","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2021.06.022_bib78","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1055\/s-0040-1712103","article-title":"Exclusion of pregnant women from clinical trials during the coronavirus disease 2019 pandemic: a review of international registries","volume":"37","author":"Smith","year":"2020","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.jacc.2021.06.022_bib79","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/eahr.500060","article-title":"Pregnant women in trials of Covid-19: a critical time to consider ethical frameworks of inclusion in clinical trials","volume":"42","author":"Farrell","year":"2020","journal-title":"Ethics Hum Res"},{"key":"10.1016\/j.jacc.2021.06.022_bib80","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1161\/CIRCRESAHA.116.307547","article-title":"Cardiovascular disease in women: clinical perspectives","volume":"118","author":"Garcia","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2021.06.022_bib81","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1161\/CIRCULATIONAHA.118.037137","article-title":"Twenty year trends and sex differences in\u00a0young adults hospitalized with acute myocardial infarction","volume":"139","author":"Arora","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2021.06.022_bib82","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1016\/j.jacc.2019.09.065","article-title":"Outcomes of women compared with men after non-ST-segment elevation acute coronary syndromes","volume":"74","author":"Sarma","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2021.06.022_bib83","article-title":"Presentation, clinical profile, and prognosis of young patients with myocardial infarction with nonobstructive coronary arteries (MINOCA): results from the VIRGO Study","volume":"7","author":"Safdar","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2021.06.022_bib84","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.amjmed.2019.10.020","article-title":"Risk factors and outcomes of very young adults who experience myocardial infarction: the Partners YOUNG-MI Registry","volume":"133","author":"Yang","year":"2020","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2021.06.022_bib85","first-page":"13","article-title":"Contemporary drug treatment of chronic heart failure with reduced ejection fraction: the CHECK-HF Registry","volume":"7","author":"Brunner-La Rocca","year":"2019","journal-title":"J\u00a0Am Coll Cardiol HF"},{"key":"10.1016\/j.jacc.2021.06.022_bib86","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.amjcard.2009.02.057","article-title":"Age- and gender-related differences in quality of care and outcomes of patients hospitalized with heart failure (from OPTIMIZE-HF)","volume":"104","author":"Fonarow","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2021.06.022_bib87","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1001\/jamainternmed.2015.0924","article-title":"A\u00a0contemporary appraisal of the heart failure epidemic in Olmsted County, Minnesota, 2000 to 2010","volume":"175","author":"Gerber","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jacc.2021.06.022_bib88","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa1908655","article-title":"Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction","volume":"381","author":"Solomon","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2021.06.022_bib89","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa1313731","article-title":"Spironolactone for heart failure with preserved ejection fraction","volume":"370","author":"Pitt","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2021.06.022_bib90","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1056\/NEJMoa1510774","article-title":"Isosorbide mononitrate in heart failure with preserved ejection fraction","volume":"373","author":"Redfield","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2021.06.022_bib91","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1161\/CIRCULATIONAHA.118.034271","article-title":"Sex differences in cardiovascular pathophysiology: why women are overrepresented in heart failure with preserved ejection fraction","volume":"138","author":"Beale","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2021.06.022_bib92","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1161\/CIRCULATIONAHA.118.037369","article-title":"Sex differences in advanced heart failure therapies","volume":"139","author":"Hsich","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2021.06.022_bib93","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1056\/NEJMoa1900486","article-title":"A\u00a0fully magnetically levitated left ventricular assist device - final report randomized controlled trial","volume":"380","author":"Mehra","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2021.06.022_bib94","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1161\/CIRCULATIONAHA.119.045204","article-title":"Advancing research on the complex interrelations between atrial fibrillation and heart failure: a report from a US National Heart, Lung, and Blood Institute Virtual Workshop","volume":"141","author":"Al-Khatib","year":"2020","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.jacc.2021.06.022_bib95","article-title":"Sex differences in symptom presentation in acute coronary syndromes: a systematic review and meta-analysis","volume":"9","author":"van Oosterhout","year":"2020","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2021.06.022_bib96","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1161\/CIRCULATIONAHA.120.052339","article-title":"Sex, permanent drug discontinuation and study retention in clinical trials: insights from the TIMI trials","volume":"143","author":"Lau","year":"2021","journal-title":"Circulation"},{"issue":"25","key":"10.1016\/j.jacc.2021.06.022_bib97","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1093\/eurheartj\/ehy377","article-title":"Standardized classification and framework for reporting, interpreting, and analysing medication non-adherence in cardiovascular clinical trials: a consensus report from the Non-adherence Academic Research Consortium (NARC)","volume":"40","author":"Valgimigli","year":"2019","journal-title":"Eur Heart J"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073510972105395X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073510972105395X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:44:47Z","timestamp":1760017487000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073510972105395X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":96,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S073510972105395X"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2021.06.022","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increasing Participation of Women in Cardiovascular Trials","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2021.06.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}